We are live on ! Find out more
DC

Davenport & Co Portfolio holdings

AUM $20.4B
1-Year Est. Return 18.11%
This Fund
S&P 500
This Quarter Est. Return
+0.23%
1 Year Est. Return
+18.11%
3 Year Est. Return
+63.26%
5 Year Est. Return
+74.4%
10 Year Est. Return
+287.26%
AUM
$17.7B
AUM Growth
+$60.4M
Cap. Flow
+$209M
Cap. Flow %
1.18%
Top 10 Hldgs %
18.86%
Holding
1,213
New
72
Increased
562
Reduced
438
Closed
64

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$59.8M
2
NVO
Novo Nordisk
NVO
+$48.8M
3
UNH icon
UnitedHealth
UNH
+$46.4M
4
UBER icon
Uber
UBER
+$37M
5
SNY icon
Sanofi
SNY
+$33.8M

Sector Composition

Rank Sector Weight
1 Financials 16.48%
2 Technology 15.4%
3 Healthcare 11.21%
4 Consumer Discretionary 9.96%
5 Industrials 9.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEAM icon
476
Atlassian
TEAM
$28B
$2.04M 0.01%
8,401
-2,151
-20% -$493K
VV icon
477
Vanguard Morningstar Large-Cap ETF
VV
$54.2B
$2.04M 0.01%
7,580
-236
-3% -$63.9K
PYLD icon
478
PIMCO Multi Sector Bond Active ETF
PYLD
$15.1B
$2.04M 0.01%
78,800
+63,577
+418% +$1.66M
VST icon
479
Vistra
VST
$48.3B
$2.03M 0.01%
14,754
+5,467
+59% +$759K
OMC icon
480
Omnicom Group
OMC
$22.4B
$2.02M 0.01%
23,510
-476
-2% -$47.2K
RBC icon
481
RBC Bearings
RBC
$17.9B
$2.02M 0.01%
6,761
-317
-4% -$97.6K
NOC icon
482
Northrop Grumman
NOC
$78.4B
$1.99M 0.01%
4,237
+288
+7% +$145K
MAA icon
483
Mid-America Apartment Communities
MAA
$15.5B
$1.98M 0.01%
12,912
-9
-0.1% -$1.41K
IMCV icon
484
iShares Morningstar Mid-Cap Value ETF
IMCV
$1.16B
$1.96M 0.01%
26,448
+11,315
+75% +$875K
IBB icon
485
iShares Biotechnology ETF
IBB
$9.39B
$1.95M 0.01%
14,756
-480
-3% -$67.5K
CHH icon
486
Choice Hotels
CHH
$4.94B
$1.93M 0.01%
13,588
-316
-2% -$44.7K
AMGN icon
487
CALL
Amgen
AMGN
$210B
$1.93M 0.01%
7,400
FAST icon
488
Fastenal
FAST
$57B
$1.92M 0.01%
53,274
-1,428
-3% -$55.7K
CVS icon
489
CVS Health
CVS
$133B
$1.91M 0.01%
42,619
-19,107
-31% -$1.07M
EQT icon
490
EQT Corp
EQT
$33B
$1.9M 0.01%
41,217
-3,908
-9% -$161K
OUSA icon
491
ALPS O'Shares U.S. Quality Dividend ETF
OUSA
$762M
$1.89M 0.01%
35,666
+23
+0.1% +$1.25K
ROIV icon
492
Roivant Sciences
ROIV
$25B
$1.89M 0.01%
160,140
-101,300
-39% -$1.2M
PHYS icon
493
Sprott Physical Gold
PHYS
$14.7B
$1.89M 0.01%
94,010
-3,171
-3% -$65.2K
KBWP icon
494
Invesco KBW Property & Casualty Insurance ETF
KBWP
$273M
$1.89M 0.01%
16,272
+183
+1% +$21.7K
BBVA icon
495
Banco Bilbao Vizcaya Argentaria
BBVA
$155B
$1.89M 0.01%
194,087
-2,370
-1% -$23.4K
PSLV icon
496
Sprott Physical Silver Trust
PSLV
$12.3B
$1.89M 0.01%
195,452
-3,802
-2% -$40.1K
FMX icon
497
Fomento Económico Mexicano
FMX
$43B
$1.88M 0.01%
21,982
-522
-2% -$48.5K
PPLI
498
People Inc
PPLI
$3.45B
$1.88M 0.01%
53,081
+2,581
+5% +$103K
JBTM
499
JBT Marel
JBTM
$6.9B
$1.86M 0.01%
14,652
-699
-5% -$80.7K
RIO icon
500
Rio Tinto
RIO
$161B
$1.85M 0.01%
31,431
-325
-1% -$20.8K

Similar funds

Davenport & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Davenport & Co held 1,213 positions worth $17.7B, up 0.34% from $17.6B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Davenport & Co's Q4 2024 filing shows 72 new, 562 increased, 438 reduced and 64 closed positions. Its largest new stake was Kirby Corp: 155,000 shares worth $16.4M. The largest sale was Walt Disney, an estimated $186M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Davenport & Co's largest Q4 2024 buy was Kirby Corp: 155,000 shares worth $16.4M.
  • Davenport & Co added most to Merck in Q4 2024, an estimated $59.8M increase.
  • Davenport & Co's biggest Q4 2024 reduction was Walt Disney, cutting an estimated $186M.
  • Davenport & Co fully exited Crown Holdings in Q4 2024, selling an estimated $2.69M.
  • Davenport & Co's ten largest holdings make up 19% of its $17.7B portfolio in Q4 2024.
  • Davenport & Co opened 72 new positions and closed 64 in Q4 2024.
  • Davenport & Co's portfolio value rose 0.34% quarter-over-quarter to $17.7B.

Based on Davenport & Co's 13F filing for Q4 2024, filed 24 Jan 2025.